Antineoplastic prescription among patients with colorectal cancer in eight major cities of China, 2015–2019: an observational retrospective database analysis

OBJECTIVES: It is unclear what is driving rising colorectal cancer (CRC) treatment costs in China, whether an adjustment in drug prices changes use and total cost. This study aims to estimate trends in drug use, prescribing patterns and spending for antineoplastic drug therapies for CRC in major cit...

Descripción completa

Detalles Bibliográficos
Autores principales: Yao, Difei, Yu, Lingyan, He, Wei, Hu, Yangmin, Xu, Huimin, Yuan, Ying, Dai, Haibin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Pharmacology and Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8552170/
https://www.ncbi.nlm.nih.gov/pubmed/34706945
http://dx.doi.org/10.1136/bmjopen-2020-046166

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8552170/
https://www.ncbi.nlm.nih.gov/pubmed/34706945
http://dx.doi.org/10.1136/bmjopen-2020-046166

Ejemplares similares